Potassium and Blood Pressure: The Mineral Most People Don't Get Enough Of

Potassium's blood pressure-lowering mechanism operates through several interconnected pathways, with the kidney as the central site of action. The sodium-potassium ATPase pump in renal tubular cells actively transports potassium into cells and sodium out, contributing to the electrochemical gradient that drives sodium reabsorption from the tubular fluid. When dietary potassium is high, this transport system reduces net sodium reabsorption, causing more sodium to be excreted in urine. This natriuresis — increased urinary sodium excretion — reduces the sodium load driving fluid retention and blood volume expansion that underlies hypertension. Potassium also directly relaxes arterial smooth muscle cells by hyperpolarising the cell membrane, reducing vasoconstriction and improving vascular compliance. Additionally, higher potassium blunts the activity of the renin-angiotensin-aldosterone system, reducing the hormonal signalling that would otherwise promote sodium retention and vasoconstriction. A meta-analysis published in the British Medical Journal analysed 33 randomised trials and found that increased potassium intake reduced systolic blood pressure by an average of 3.5 mmHg and diastolic by 2.0 mmHg, with substantially greater reductions — up to 7 mmHg systolic — in people with established hypertension. These effects are most pronounced on a background of high sodium intake, confirming that the sodium-to-potassium ratio is the key variable. Population studies consistently show that populations with high potassium and low sodium intake — such as communities eating traditional, plant-rich diets — have very low rates of hypertension and age-related blood pressure rise.

True clinical hypokalaemia (serum potassium below 3.5 mmol/L) most commonly results from excessive losses rather than dietary deficiency alone — causes include prolonged vomiting, diarrhoea, diuretic use, excessive sweating, and certain kidney disorders. Symptoms of significant deficiency include muscle weakness, cramping, fatigue, and constipation, reflecting potassium's role in muscle cell membrane potential. Cardiac arrhythmias are the most dangerous consequence: potassium is critical for repolarising cardiac muscle cells after each contraction, and low potassium increases susceptibility to potentially fatal ventricular arrhythmias, particularly in people with underlying heart disease or those taking digoxin. At subclinical levels — insufficient intake that does not produce outright hypokalaemia but maintains blood potassium in the lower normal range — the effects are subtler but meaningfully impact long-term health. Chronically low dietary potassium is associated with higher blood pressure, increased risk of kidney stones (through mechanisms involving urinary calcium excretion and urinary citrate), and greater risk of stroke. The kidney stone relationship is particularly interesting: potassium citrate supplements are used clinically to prevent calcium oxalate stones by alkalinising the urine and chelating calcium. Beyond cardiovascular outcomes, potassium is required for adequate insulin secretion from pancreatic beta cells, and low potassium states impair glucose tolerance — a relationship that may contribute to the metabolic consequences of diuretic-induced potassium depletion and to the metabolic benefits of potassium-rich diets observed in population studies.

Potassium is found abundantly in whole plant foods, with particularly high concentrations in vegetables, legumes, and fruits. White potatoes with their skin are often overlooked in this context: a medium baked potato provides approximately 900mg of potassium — more than twice the amount in a medium banana, which provides around 420mg. Sweet potatoes are similarly impressive at roughly 700mg per medium serving. Among vegetables, tomato paste and puree are among the most concentrated sources, with 570mg per two tablespoons of paste; a cup of cooked Swiss chard provides 960mg; cooked spinach offers 839mg; and avocado around 690mg per whole fruit. Legumes are an excellent source: white beans provide approximately 1000mg per cooked cup, edamame around 676mg, lentils 731mg, and kidney beans 717mg. Among fruits, dried apricots and prunes are highly concentrated at 1500–1600mg per 100g; a medium banana provides 420mg; a cup of orange juice approximately 496mg; and a medium avocado roughly 690mg. Animal foods also contribute: a 100g serving of salmon provides about 555mg, chicken breast around 256mg, and an 8-ounce glass of cow's milk approximately 380mg. The practical implication of this distribution is clear: diets centred around vegetables, legumes, and whole fruits naturally provide generous potassium, while highly processed diets stripped of plant foods predictably fall short. Salt substitutes using potassium chloride in place of sodium chloride can meaningfully boost intake — a recent large trial in rural China found significant cardiovascular benefit from this substitution.

The Dietary Approaches to Stop Hypertension (DASH) diet was specifically developed and tested as a dietary intervention for blood pressure reduction, and its efficacy is supported by multiple large randomised controlled trials. The DASH diet emphasises fruits, vegetables, low-fat dairy, whole grains, legumes, nuts, and seeds while limiting red meat, saturated fat, sweets, and sodium. Its potassium target is approximately 4700mg per day — significantly above typical Western intakes — and the diet typically provides 3–4 times more potassium than a standard American or British diet. The original DASH trial demonstrated an average reduction of 11.4 mmHg systolic and 5.5 mmHg diastolic in people with hypertension — effects comparable to single-drug antihypertensive therapy. A subsequent trial, DASH-Sodium, showed that combining the DASH diet with sodium reduction produced even greater blood pressure reductions. Mechanistically, the DASH diet's blood pressure benefits are likely driven by the combined effects of higher potassium, magnesium, and calcium alongside lower sodium and saturated fat, rather than potassium alone — consistent with the synergistic model of mineral interactions in blood pressure regulation. Several large prospective cohort studies have found that higher DASH diet adherence scores predict significantly lower risk of stroke, coronary heart disease, heart failure, and overall cardiovascular mortality, as well as reduced risk of type 2 diabetes and certain cancers. The DASH diet has also been shown to reduce markers of oxidative stress and inflammation, consistent with its whole-food, plant-rich composition.

For most healthy adults with no kidney disease, increasing dietary potassium through food is both the safest and most effective strategy. However, there are specific circumstances where potassium supplementation or prescription potassium therapy is appropriate. People taking diuretic medications — particularly loop diuretics (furosemide, bumetanide) and thiazide diuretics used for hypertension or heart failure — commonly lose significant potassium in urine and frequently require potassium supplements or potassium-sparing diuretics to prevent hypokalaemia. People with conditions causing chronic potassium losses — including primary aldosteronism, renal tubular acidosis, prolonged diarrhoea, and severe alcoholism — may also require supplemental potassium under medical supervision. Over-the-counter potassium supplements are available but are tightly limited to 99mg of elemental potassium per tablet in the US by FDA regulation — far below the 4700mg daily intake target — due to concerns about the risk of gastrointestinal irritation from larger potassium tablets and the potential for dangerous hyperkalaemia in vulnerable individuals, particularly those with kidney disease or those on renin-angiotensin-aldosterone-blocking medications. This regulatory limit means that food-based potassium is the practical route to meeting adequate intake for most people. Potassium chloride-based salt substitutes can provide substantially more potassium per day and represent a practical option for those wishing to increase intake beyond what their usual diet provides, provided they do not have kidney disease or use medications that raise potassium. The PATHWAY-3 trial demonstrated significant blood pressure and mortality benefits from potassium chloride salt substitution in large community populations.